26 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation … and the registrar for the Ordinary Shares or the ADSs (x) the filing and other fees incident to any review by FINRA of the terms of the sale
424B3
y3a5woggy0 kl
29 Apr 21
Prospectus supplement
6:10am
S-3
p7mg ze00lkbnz5va4c0
15 Apr 21
Shelf registration
4:03pm
8-K
EX-10.1
0eudeuys
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
S-4
EX-10.6
khoedozvodbd oj42
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-2.1
ycgmq 41sb365qg
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.7
utmcb
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
vjtspi
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
11mgr54
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-1.1
q689ehqv2hu x8vs
14 Feb 19
Current report (foreign)
4:40pm
424B4
mym88vhp
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
nygm6sivlp wctiy9
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
cuhb9af68apu
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
2k6c571
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
24fezcc8 5p
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.2
7ip31xe8f6fqh9
7 Jan 19
Registration statement (foreign)
5:11pm